Tag: ulcerative colitis support
After Surgery, IBD Can Still Surprise Us: A Facial Wound’s Message
A woman who thought her ulcerative colitis was cured by surgery developed a rare facial skin condition years later, revealing that IBD can continue affecting the body in unexpected ways. This case highlights why ongoing vigilance and comprehensive care remain important even after major IBD surgery.
New Once-Monthly UC Treatment Approved: What Patients Need to Know
The FDA has approved Omvoh, the first once-monthly injection for ulcerative colitis maintenance therapy. This breakthrough could significantly reduce treatment burden for people with moderate to severe UC.
New Clinical Leader Brings Hope to GI Treatment Development
Palisade Bio has appointed Dr. Sharon Skare as VP of Clinical Operations to advance PALI-2108, a promising new GI therapy. Her 30+ years of experience could accelerate development of treatments for conditions with limited options.
Hidden Gut Engine Discovery Offers New Hope for Crohn’s Patients
Scientists have discovered a ‘hidden hydrogen engine’ in the gut that malfunctions in Crohn’s disease, potentially explaining digestive symptoms and opening doors to new diagnostic tools and treatments. This research offers hope for more personalized approaches to managing IBD.
Better IBD Treatments on the Horizon: What Growth Means for Patients
Market analysis shows unprecedented growth in IBD research and treatment development, with new biologics, personalized medicine, and digital health platforms on the horizon. Here’s what this expansion means for patients and families managing Crohn’s disease and ulcerative colitis.
Could This Overlooked Gut Bacteria Be a Game-Changer for IBD?
New research identifies Ruminococcus torques, a gut bacterium that strengthens the intestinal barrier and may offer new hope for IBD management. This discovery could lead to more targeted, microbiome-based therapies for inflammatory bowel disease.
Tremfya Breakthrough: First At-Home UC Treatment Changes Everything
The European Commission has approved Tremfya as the first IL-23 inhibitor that can be self-administered at home for UC treatment. This groundbreaking approval could transform how patients manage moderate to severe ulcerative colitis by eliminating the need for hospital infusions.
The Mediterranean Diet for UC: Why This Matters for Your Journey
New research suggests the Mediterranean-Style Diet could help people with ulcerative colitis by focusing on anti-inflammatory foods and flexible eating patterns. This approach shifts from restriction to nourishment, offering hope for better symptom management.
Understanding IBD: What Everyone Should Know About Crohn’s and UC
Living with IBD means facing daily uncertainty, but understanding the differences between Crohn’s disease and ulcerative colitis can help you better advocate for yourself. We break down what these conditions mean for your daily life and long-term health journey.
When Your Battle Is Invisible: Understanding Life With IBD
Living with IBD means fighting a daily battle that often remains invisible to others. A recent article sheds light on the unique challenges of inflammatory bowel disease and why greater awareness matters for our community.
